Research
Over the past two decades tissue‐type plasminogen activator (t‐PA), the main physiological plasminogen activator, has been developed as a fibrin‐specific thrombolytic agent for the treatment of various thromboembolic diseases.
Lab Corp has some information regarding tests https://www.labcorp.com/tests/123023/oxidized-low-density-lipoprotein-oxldl